SM
MDCO

Sabby Management’s Medicines Co MDCO Stock Holding History

Sabby Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-11,764
Closed -$434K – 234
2017
Q2 		$447K Buy
+11,764
New +$524K 0.03% 148
2017
Q1 		– Sell
-112,392
Closed -$5.13M – 350
2016
Q4 		$3.81M Buy
112,392
+98,884
+732% +$3.51M 0.22% 66
2016
Q3 		$510K Buy
13,508
+6,508
+93% +$245K 0.02% 224
2016
Q2 		$235K Buy
+7,000
New +$247K 0.01% 240
2014
Q3 		– Sell
-7,948
Closed -$202K – 318
2014
Q2 		$231K Buy
+7,948
New +$212K 0.01% 221

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
TBC
Three Bays Capital Boston, Massachusetts $848M AUM 7.41% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sabby Management's MDCO Position: Q3 2017 in Review

Sabby Management sold out of Medicines Co (MDCO) in Q3 2017, closing a stake of 11,764 shares — an estimated $434K sold.

Sabby Management first reported a position in MDCO in Q2 2014 and held it in 5 quarters. The position peaked at $3.81M in Q4 2016. 190 funds tracked by Wall St. Rank hold MDCO as of Q3 2017.

  • Sabby Management reported no remaining Medicines Co position as of Q3 2017 after selling out during the quarter.
  • Sabby Management sold 11,764 Medicines Co shares in Q3 2017, an estimated $434K.
  • Sabby Management first reported a position in Medicines Co in Q2 2014 and held it in 5 quarters.
  • Sabby Management's Medicines Co position peaked at $3.81M in Q4 2016.
  • 190 funds tracked by Wall St. Rank held Medicines Co as of Q3 2017.

Based on Sabby Management's 13F filing for Q3 2017, filed 14 Nov 2017.